202 related articles for article (PubMed ID: 35857775)
1. Reduced affinity of calcium sensing-receptor heterodimers and reduced mutant homodimer trafficking combine to impair function in a model of familial hypocalciuric hypercalcemia type 1.
Wang X; Lundblad J; Smith SM
PLoS One; 2022; 17(7):e0266993. PubMed ID: 35857775
[TBL] [Abstract][Full Text] [Related]
2. Calcium signaling regulates trafficking of familial hypocalciuric hypercalcemia (FHH) mutants of the calcium sensing receptor.
Grant MP; Stepanchick A; Breitwieser GE
Mol Endocrinol; 2012 Dec; 26(12):2081-91. PubMed ID: 23077345
[TBL] [Abstract][Full Text] [Related]
3. Cell Surface Calcium-Sensing Receptor Heterodimers: Mutant Gene Dosage Affects Ca
Goolam MA; Brown AP; Edwards KT; Gregory KJ; Leach K; Conigrave AD
J Bone Miner Res; 2022 Sep; 37(9):1787-1807. PubMed ID: 35848051
[TBL] [Abstract][Full Text] [Related]
4. Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
Bai M; Janicic N; Trivedi S; Quinn SJ; Cole DE; Brown EM; Hendy GN
J Clin Invest; 1997 Apr; 99(8):1917-25. PubMed ID: 9109436
[TBL] [Abstract][Full Text] [Related]
5. Identification and Functional Characterization of a Calcium-Sensing Receptor Mutation in an Infant with Familial Hypocalciuric Hypercalcemia.
Papadopoulou A; Gole E; Melachroinou K; Meristoudis C; Siahanidou T; Papadimitriou A
J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):341-6. PubMed ID: 27087013
[TBL] [Abstract][Full Text] [Related]
6. Identification and functional characterization of loss-of-function mutations of the calcium-sensing receptor in four Italian kindreds with familial hypocalciuric hypercalcemia.
Cetani F; Lemmi M; Cervia D; Borsari S; Cianferotti L; Pardi E; Ambrogini E; Banti C; Brown EM; Bagnoli P; Pinchera A; Marcocci C
Eur J Endocrinol; 2009 Mar; 160(3):481-9. PubMed ID: 19073830
[TBL] [Abstract][Full Text] [Related]
7. Identification and functional analysis of a novel CaSR mutation in a family with familial hypocalciuric hypercalcemia.
Kim ES; Kim SY; Lee JY; Han JH; Sohn TS; Son HS; Moon SD
J Bone Miner Metab; 2016 Nov; 34(6):662-667. PubMed ID: 26386835
[TBL] [Abstract][Full Text] [Related]
8. Heterozygous Mutation (Q459R) in the Calcium-Sensing Receptor Gene Causes Familial Hypocalciuric Hypercalcemia 1 (FHH1).
Boisen IM; Mos I; Lerche-Black EM; Juul A; Bräuner-Osborne H; Blomberg Jensen M
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32160303
[TBL] [Abstract][Full Text] [Related]
9. Personalised medicines for familial hypercalcemia and hyperparathyroidism.
Josephs TM; Zhang F; Dinh LV; Keller AN; Conigrave AD; Capuano B; Gregory KJ; Leach K
J Mol Endocrinol; 2022 May; 69(1):243-257. PubMed ID: 35318962
[TBL] [Abstract][Full Text] [Related]
10. Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia.
Pidasheva S; Canaff L; Simonds WF; Marx SJ; Hendy GN
Hum Mol Genet; 2005 Jun; 14(12):1679-90. PubMed ID: 15879434
[TBL] [Abstract][Full Text] [Related]
11. A G-protein Subunit-α11 Loss-of-Function Mutation, Thr54Met, Causes Familial Hypocalciuric Hypercalcemia Type 2 (FHH2).
Gorvin CM; Cranston T; Hannan FM; Rust N; Qureshi A; Nesbit MA; Thakker RV
J Bone Miner Res; 2016 Jun; 31(6):1200-6. PubMed ID: 26729423
[TBL] [Abstract][Full Text] [Related]
12. A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia.
Hannan FM; Nesbit MA; Christie PT; Lissens W; Van der Schueren B; Bex M; Bouillon R; Thakker RV
Clin Endocrinol (Oxf); 2010 Dec; 73(6):715-22. PubMed ID: 20846291
[TBL] [Abstract][Full Text] [Related]
13. New mutation in the CASR gene in a family with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT).
Rodrigues LS; Cáu AC; Bussmann LZ; Bastida G; Brunetto OH; Corrêa PH; Martin RM
Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):67-71. PubMed ID: 21468522
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
[TBL] [Abstract][Full Text] [Related]
15. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
[TBL] [Abstract][Full Text] [Related]
16. Heterozygous inactivating CaSR mutations causing neonatal hyperparathyroidism: function, inheritance and phenotype.
Glaudo M; Letz S; Quinkler M; Bogner U; Elbelt U; Strasburger CJ; Schnabel D; Lankes E; Scheel S; Feldkamp J; Haag C; Schulze E; Frank-Raue K; Raue F; Mayr B; Schöfl C
Eur J Endocrinol; 2016 Nov; 175(5):421-31. PubMed ID: 27666534
[TBL] [Abstract][Full Text] [Related]
17. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia.
D'Souza-Li L; Yang B; Canaff L; Bai M; Hanley DA; Bastepe M; Salisbury SR; Brown EM; Cole DE; Hendy GN
J Clin Endocrinol Metab; 2002 Mar; 87(3):1309-18. PubMed ID: 11889203
[TBL] [Abstract][Full Text] [Related]
18. The pathophysiology of primary hyperparathyroidism.
Brown EM
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N24-9. PubMed ID: 12412774
[TBL] [Abstract][Full Text] [Related]
19. Two novel mutations of the calcium-sensing receptor gene affecting the same amino acid position lead to opposite phenotypes and reveal the importance of p.N802 on receptor activity.
Lia-Baldini AS; Magdelaine C; Nizou A; Airault C; Salles JP; Moulin P; Delemer B; Aitouares M; Funalot B; Sturtz F; Lienhardt-Roussie A
Eur J Endocrinol; 2013 Feb; 168(2):K27-34. PubMed ID: 23169696
[TBL] [Abstract][Full Text] [Related]
20. An adult patient with severe hypercalcaemia and hypocalciuria due to a novel homozygous inactivating mutation of calcium-sensing receptor.
Chikatsu N; Fukumoto S; Suzawa M; Tanaka Y; Takeuchi Y; Takeda S; Tamura Y; Matsumoto T; Fujita T
Clin Endocrinol (Oxf); 1999 Apr; 50(4):537-43. PubMed ID: 10468915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]